Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CSP #2037T - Veterans Affairs Learning Health System Initiative to Assess Novel Screening vs. Usual Care and Treatment With Apixaban vs. Rivaroxaban in Veterans With Atrial Fibrillation (VALIANT-AF-T) Trial

NCT06953726 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT06953726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06953726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CSP #2037T - Veterans Affairs Learning Health System Initiative to Assess Novel Screening vs. Usual Care and Treatment With Apixaban vs. Rivaroxaban in Veterans With Atrial Fibrillation (VALIANT-AF-T) Trial
Lead sponsor
VA Office of Research and Development
Phase
Phase 4
Overall status
Recruiting
Start date
June 1, 2026
Completion date
October 3, 2033
Enrollment
10,000 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation